These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36741731)

  • 1. Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE database.
    Pestana RC; Serrano C
    Front Oncol; 2022; 12():1079909. PubMed ID: 36741731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications.
    Gouda MA; Nelson BE; Buschhorn L; Wahida A; Subbiah V
    Clin Cancer Res; 2023 Aug; 29(15):2753-2760. PubMed ID: 37061987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical Implications.
    Denu RA; Moyers JT; Gouda MA; Conley AP; Lazar AJ; Subbiah V
    Clin Cancer Res; 2023 Nov; 29(22):4669-4678. PubMed ID: 37643131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Profiling and Clinical Outcomes of Targeted Therapies in Adult Patients with Soft Tissue Sarcomas.
    Kokkali S; Georgaki E; Mandrakis G; Valverde C; Theocharis S
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tissue-agnostic approvals for patients with sarcoma.
    Pestana RC; Beal JR; Parkes A; Hamerschlak N; Subbiah V
    Trends Cancer; 2022 Feb; 8(2):135-144. PubMed ID: 34887213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets.
    Roszik J; Khan A; Conley AP; Livingston JA; Groisberg R; Ravi V; Carmagnani Pestana R; Sen S; Subbiah V
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy.
    Lucchesi C; Khalifa E; Laizet Y; Soubeyran I; Mathoulin-Pelissier S; Chomienne C; Italiano A
    JAMA Oncol; 2018 Oct; 4(10):1398-1404. PubMed ID: 29801054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics.
    Tateo V; Marchese PV; Mollica V; Massari F; Kurzrock R; Adashek JJ
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of biomarker testing in historically rare, high-unmet-need tumors: soft tissue sarcomas and thyroid cancers.
    Schroader B; Kong S; Anderson S; Williamson T; Sireci A; Shields K
    Expert Rev Anticancer Ther; 2019 Nov; 19(11):929-938. PubMed ID: 31622558
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
    Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
    Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histology-agnostic drug development - considering issues beyond the tissue.
    Pestana RC; Sen S; Hobbs BP; Hong DS
    Nat Rev Clin Oncol; 2020 Sep; 17(9):555-568. PubMed ID: 32528101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
    Zaki MM; Mashouf LA; Woodward E; Langat P; Gupta S; Dunn IF; Wen PY; Nahed BV; Bi WL
    Sci Rep; 2021 Sep; 11(1):18009. PubMed ID: 34504233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving landscape of tissue-agnostic therapies in precision oncology.
    Subbiah V; Gouda MA; Ryll B; Burris HA; Kurzrock R
    CA Cancer J Clin; 2024; 74(5):433-452. PubMed ID: 38814103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?
    Weis LN; Tolaney SM; Barrios CH; Barroso-Sousa R
    NPJ Breast Cancer; 2021 Sep; 7(1):120. PubMed ID: 34518552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Medicine in Oncology: A Review of Multi-Tumor Actionable Molecular Targets with an Emphasis on Non-Small Cell Lung Cancer.
    Stein MK; Oluoha O; Patel K; VanderWalde A
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34198738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas.
    Sethi TK; Keedy VL
    Curr Treat Options Oncol; 2016 Feb; 17(2):11. PubMed ID: 26931561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA Approvals of Oncology Drugs for Tissue-Agnostic Indications.
    Zettler ME
    Target Oncol; 2023 Sep; 18(5):777-792. PubMed ID: 37477750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highlights in soft tissue sarcomas and gastrointestinal stromal tumours (GIST) trials reported at ASCO 2017 Annual Meeting.
    Frezza AM; Stacchiotti S; Gronchi A
    BMC Med; 2017 Aug; 15(1):160. PubMed ID: 28826404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.